Hematology and Immunology Strategic Portfolio Supports Sobi's Narrow Moat
Given Sobi's cash flow generation from its hemophilia business and mature product Synagis, the firm ended 2024 with a net debt/EBITDA ratio of 1.6 times. We expect the firm can support this level of ...
Tempur Sealy to change name to Somnigroup, ticker to ‘SGI’
In connection with the closing of its acquisition of Mattress Firm, Tempur Sealy International (TPX) announced it will change its name to ...
Agrify appoints Peter Shapiro, Sanjay Tolia to board of directors
Corporation announced that Peter Shapiro and Sanjay Tolia have been appointed to its Board of Directors, effective January 31, ...